Evidence map›Paper›PMID 33468699›Full record

ArticlemBio2021

Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.

Sudeshna Saha, Alison Coady, Aniruddha Sasmal, Kunio Kawanishi, Biswa Choudhury, Hai Yu, Ricardo U Sorensen, Jaime Inostroza, Ian C Schoenhofen, Xi Chen and 6 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  6. Siglec-9 is an inhibitory receptor on human mast cells in vitro.The Journal of allergy and clinical immunology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Sudeshna SahaGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0002-8195-6981
Alison CoadyGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.
Aniruddha SasmalGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.
Kunio KawanishiGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0003-3502-3467
Biswa ChoudhuryGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.
Hai YuDepartment of Chemistry, University of California, Davis, California, USA.ORCID 0000-0002-4378-0532
Ricardo U SorensenDepartment of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Jaime InostrozaDepartment of Basic Sciences, School of Medicine, Universidad de La Frontera, Temuco, Chile.
Ian C SchoenhofenHuman Health Therapeutics Research Center, National Research Council of Canada, Ottawa, Ontario, Canada.
Xi ChenDepartment of Chemistry, University of California, Davis, California, USA.ORCID 0000-0002-3160-614X
Anja Münster-KühnelClinical Biochemistry, Hannover Medical School, Hannover, Germany.
Chihiro SatoBioscience and Biotechnology Center, Nagoya University, Nagoya, Japan.
Ken KitajimaBioscience and Biotechnology Center, Nagoya University, Nagoya, Japan.
Sanjay RamDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Victor NizetGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0003-3847-0422
Ajit VarkiGlycobiology Research and Training Center, University of California, San Diego, La Jolla, California, USA a1varki@health.ucsd.edu.ORCID 0000-0002-2206-975X
University of California San Diego · USNagoya University · JPUniversity of California, Davis · USLouisiana State University Health Sciences Center New Orleans · USMedizinische Hochschule Hannover · DENational Research Council Canada · CAUniversidad de La Frontera · CLUniversity of Massachusetts Chan Medical School · US

Funding

BIOSYNTHESIS AND REGULATION OF SUBSTITUTED SIALIC ACIDSR01GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 1985 to 2022
$6.9M
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial PathogenesisR01AI145325 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR, RAFFATELLU, MANUELA · 2019 to 2023
$3.1M
NIAID NIH HHS R01 AI145325NIGMS NIH HHS R01 GM032373
6 · The paper itself

Abstract

Surface expression of the common vertebrate sialic acid (Sia)

Indexed as

AnimalsAntibodiesAntigens, CDBiological TransportComplement C3FemaleGlycoconjugatesHaemophilus InfectionsHaemophilus influenzaeHost-Pathogen InteractionsHumansImmunoglobulin MMiceMice, Inbred C57BLMolecular MimicryN-Acetylneuraminic AcidAntibodiesAntigens, CDComplement C3GlycoconjugatesImmunoglobulin MN-Acetylneuraminic AcidSialic Acid Binding Immunoglobulin-like LectinsSialic Acidssiglec-9 protein, mouseSugar Acidsantibodybacterial pathogenesisCMAHglycobiologyKdnmolecular mimicryNeu5Acnontypeable Haemophilus influenzae (NTHi)sialic acid

Identifiers

PMID33468699
PMCPMC7845648
OpenAlexW3122921496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.